151 related articles for article (PubMed ID: 27009380)
1. Epidemiology, Risk Factors, and In-Hospital Mortality of Venous Thromboembolism in Liver Cirrhosis: A Single-Center Retrospective Observational Study.
Zhang X; Qi X; De Stefano V; Hou F; Ning Z; Zhao J; Peng Y; Li J; Deng H; Li H; Guo X
Med Sci Monit; 2016 Mar; 22():969-76. PubMed ID: 27009380
[TBL] [Abstract][Full Text] [Related]
2. Trends in Hospitalization and In-Hospital Mortality From VTE, 2007 to 2016, in China.
Zhang Z; Lei J; Shao X; Dong F; Wang J; Wang D; Wu S; Xie W; Wan J; Chen H; Ji Y; Yi Q; Xu X; Yang Y; Zhai Z; Wang C;
Chest; 2019 Feb; 155(2):342-353. PubMed ID: 30419233
[TBL] [Abstract][Full Text] [Related]
3. The prevalence and risk factors of venous thromboembolism in hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease.
Pang H; Wang L; Liu J; Wang S; Yang Y; Yang T; Wang C
Clin Respir J; 2018 Nov; 12(11):2573-2580. PubMed ID: 30207643
[TBL] [Abstract][Full Text] [Related]
4. Coagulopathy does not protect against venous thromboembolism in hospitalized patients with chronic liver disease.
Dabbagh O; Oza A; Prakash S; Sunna R; Saettele TM
Chest; 2010 May; 137(5):1145-9. PubMed ID: 20040609
[TBL] [Abstract][Full Text] [Related]
5. Decreased incidence of venous thromboembolism after spine surgery with early multimodal prophylaxis: Clinical article.
Cox JB; Weaver KJ; Neal DW; Jacob RP; Hoh DJ
J Neurosurg Spine; 2014 Oct; 21(4):677-84. PubMed ID: 25105337
[TBL] [Abstract][Full Text] [Related]
6. 30-year mortality after venous thromboembolism: a population-based cohort study.
Søgaard KK; Schmidt M; Pedersen L; Horváth-Puhó E; Sørensen HT
Circulation; 2014 Sep; 130(10):829-36. PubMed ID: 24970783
[TBL] [Abstract][Full Text] [Related]
7. Declining Long-term Risk of Adverse Events after First-time Community-presenting Venous Thromboembolism: The Population-based Worcester VTE Study (1999 to 2009).
Huang W; Goldberg RJ; Cohen AT; Anderson FA; Kiefe CI; Gore JM; Spencer FA
Thromb Res; 2015 Jun; 135(6):1100-6. PubMed ID: 25921936
[TBL] [Abstract][Full Text] [Related]
8. Patients with transverse myelitis who developed venous thromboembolism while hospitalized have increased rate for inpatient mortality.
Maiser S; Adil MM; Roohani P; Tariq N
J Neuroimmunol; 2013 Aug; 261(1-2):120-2. PubMed ID: 23768728
[TBL] [Abstract][Full Text] [Related]
9. Coagulopathy does not fully protect hospitalized cirrhosis patients from peripheral venous thromboembolism.
Northup PG; McMahon MM; Ruhl AP; Altschuler SE; Volk-Bednarz A; Caldwell SH; Berg CL
Am J Gastroenterol; 2006 Jul; 101(7):1524-8; quiz 1680. PubMed ID: 16863556
[TBL] [Abstract][Full Text] [Related]
10. Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).
Isma N; Svensson PJ; Gottsäter A; Lindblad B
Thromb Res; 2009 Dec; 124(6):663-6. PubMed ID: 19497611
[TBL] [Abstract][Full Text] [Related]
11. [Clinical analysis of 20 pregnant women with venous thromboembolic disease].
Sun P; Dong DN
Zhonghua Fu Chan Ke Za Zhi; 2011 Dec; 46(12):911-6. PubMed ID: 22333281
[TBL] [Abstract][Full Text] [Related]
12. Suboptimal use of pharmacological venous thromboembolism prophylaxis in cirrhotic patients.
Yang LS; Alukaidey S; Croucher K; Dowling D
Intern Med J; 2018 Sep; 48(9):1056-1063. PubMed ID: 29468795
[TBL] [Abstract][Full Text] [Related]
13. Recurrent venous thromboembolism in glioblastoma.
Edwin NC; Khoury MN; Sohal D; McCrae KR; Ahluwalia MS; Khorana AA
Thromb Res; 2016 Jan; 137():184-188. PubMed ID: 26657302
[TBL] [Abstract][Full Text] [Related]
14. Frequency and predictors of venous thromboembolism in orthotopic liver transplant recipients: a single-center retrospective review.
Salami A; Qureshi W; Kuriakose P; Moonka D; Yoshida A; Abouljoud M
Transplant Proc; 2013; 45(1):315-9. PubMed ID: 23267811
[TBL] [Abstract][Full Text] [Related]
15. Postoperative D-dimer predicts venous thromboembolism in patients undergoing urologic tumor surgery.
Shi A; Huang J; Wang X; Li M; Zhang J; Chen Y; Huang Y
Urol Oncol; 2018 Jun; 36(6):307.e15-307.e21. PubMed ID: 29599070
[TBL] [Abstract][Full Text] [Related]
16. The Incidence and Economic Burden of In-Hospital Venous Thromboembolism in the United States.
Shahi A; Chen AF; Tan TL; Maltenfort MG; Kucukdurmaz F; Parvizi J
J Arthroplasty; 2017 Apr; 32(4):1063-1066. PubMed ID: 27866951
[TBL] [Abstract][Full Text] [Related]
17. The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis.
Ambrosino P; Tarantino L; Di Minno G; Paternoster M; Graziano V; Petitto M; Nasto A; Di Minno MN
Thromb Haemost; 2017 Jan; 117(1):139-148. PubMed ID: 27761574
[TBL] [Abstract][Full Text] [Related]
18. Increased incidence of VTE in sickle cell disease patients: risk factors, recurrence and impact on mortality.
Brunson A; Lei A; Rosenberg AS; White RH; Keegan T; Wun T
Br J Haematol; 2017 Jul; 178(2):319-326. PubMed ID: 28369826
[TBL] [Abstract][Full Text] [Related]
19. Prevalence, Risk Factors and In-hospital Outcomes of QTc Interval Prolongation in Liver Cirrhosis.
Zhao J; Qi X; Hou F; Ning Z; Zhang X; Deng H; Peng Y; Li J; Wang X; Li H; Guo X
Am J Med Sci; 2016 Sep; 352(3):285-95. PubMed ID: 27650234
[TBL] [Abstract][Full Text] [Related]
20. The impact of co-morbidity on the disease burden of VTE.
Kroep S; Chuang LH; Cohen A; Gumbs P; van Hout B; Monreal M; Willich SN; Gitt A; Bauersachs R; Agnelli G
J Thromb Thrombolysis; 2018 Nov; 46(4):507-515. PubMed ID: 30218272
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
